Skip to main content
. 1999 Jul;117(1):8–11. doi: 10.1046/j.1365-2249.1999.00944.x

Fig. 2.

Fig. 2

The percentage of intracellular IFN-γ expression from CD4+ cells of the control group (n = 11) (median 51.41) compared with all B cell chronic lymphocytic leukaemia (B-CLL) patients (n = 21) (median 18) (P < 0.0016), stage A patients (n = 14) (median 19) (P < 0.0197), and stage B/C patients (n = 11) (median 12) (P < 0.0059). Stage A patients compared with stage B/C was not significant (P < 0.2874).